Tweet
Nat Biomed Eng
. 2023 Sep 7.
doi: 10.1038/s41551-023-01082-6. Online ahead of print. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
Bowen Li # 1 2 3 4 5 , Allen Yujie Jiang # 1 2 , Idris Raji # 1 2 , Caroline Atyeo 6 7 , Theresa M Raimondo 1 2 , Akiva G R Gordon 1 2 , Luke H Rhym 1 2 , Tahoura Samad 1 8 , Corina MacIsaac 1 9 , Jacob Witten 1 2 , Haseeb Mughal 1 10 , Taras M Chicz 6 , Yue Xu 3 , Ryan P McNamara 6 , Sangeeta Bhatia 1 8 9 10 11 12 13 14 15 , Galit Alter 6 , Robert Langer 1 2 8 9 , Daniel G Anderson 16 17 18 19 20
Affiliations
To elicit optimal immune responses, messenger RNA vaccines require intracellular delivery of the mRNA and the careful use of adjuvants. Here we report a multiply adjuvanted mRNA vaccine consisting of lipid nanoparticles encapsulating an mRNA-encoded antigen, optimized for efficient mRNA delivery and for the enhanced activation of innate and adaptive responses. We optimized the vaccine by screening a library of 480 biodegradable ionizable lipids with headgroups adjuvanted with cyclic amines and by adjuvanting the mRNA-encoded antigen by fusing it with a natural adjuvant derived from the C3 complement protein. In mice, intramuscular or intranasal administration of nanoparticles with the lead ionizable lipid and with mRNA encoding for the fusion protein (either the spike protein or the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) increased the titres of antibodies against SARS-CoV-2 tenfold with respect to the vaccine encoding for the unadjuvanted antigen. Multiply adjuvanted mRNA vaccines may improve the efficacy, safety and ease of administration of mRNA-based immunization.
. 2023 Sep 7.
doi: 10.1038/s41551-023-01082-6. Online ahead of print. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
Bowen Li # 1 2 3 4 5 , Allen Yujie Jiang # 1 2 , Idris Raji # 1 2 , Caroline Atyeo 6 7 , Theresa M Raimondo 1 2 , Akiva G R Gordon 1 2 , Luke H Rhym 1 2 , Tahoura Samad 1 8 , Corina MacIsaac 1 9 , Jacob Witten 1 2 , Haseeb Mughal 1 10 , Taras M Chicz 6 , Yue Xu 3 , Ryan P McNamara 6 , Sangeeta Bhatia 1 8 9 10 11 12 13 14 15 , Galit Alter 6 , Robert Langer 1 2 8 9 , Daniel G Anderson 16 17 18 19 20
Affiliations
- PMID: 37679571
- DOI: 10.1038/s41551-023-01082-6
To elicit optimal immune responses, messenger RNA vaccines require intracellular delivery of the mRNA and the careful use of adjuvants. Here we report a multiply adjuvanted mRNA vaccine consisting of lipid nanoparticles encapsulating an mRNA-encoded antigen, optimized for efficient mRNA delivery and for the enhanced activation of innate and adaptive responses. We optimized the vaccine by screening a library of 480 biodegradable ionizable lipids with headgroups adjuvanted with cyclic amines and by adjuvanting the mRNA-encoded antigen by fusing it with a natural adjuvant derived from the C3 complement protein. In mice, intramuscular or intranasal administration of nanoparticles with the lead ionizable lipid and with mRNA encoding for the fusion protein (either the spike protein or the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) increased the titres of antibodies against SARS-CoV-2 tenfold with respect to the vaccine encoding for the unadjuvanted antigen. Multiply adjuvanted mRNA vaccines may improve the efficacy, safety and ease of administration of mRNA-based immunization.